Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 2 |
Forrest at al. (procyclic) | no | yes: 2 |
Silverman et al. | no | yes: 0 |
Pissara et al. | yes | yes: 15 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 6 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 2 |
GO:0005850 | eukaryotic translation initiation factor 2 complex | 2 | 2 |
GO:0032991 | protein-containing complex | 1 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
Related structures:
AlphaFold database: Q4QIB4
Term | Name | Level | Count |
---|---|---|---|
GO:0001731 | formation of translation preinitiation complex | 7 | 2 |
GO:0001732 | formation of cytoplasmic translation initiation complex | 7 | 2 |
GO:0009987 | cellular process | 1 | 2 |
GO:0016043 | cellular component organization | 3 | 2 |
GO:0022607 | cellular component assembly | 4 | 2 |
GO:0022618 | ribonucleoprotein complex assembly | 6 | 2 |
GO:0043933 | protein-containing complex organization | 4 | 2 |
GO:0065003 | protein-containing complex assembly | 5 | 2 |
GO:0071826 | ribonucleoprotein complex subunit organization | 5 | 2 |
GO:0071840 | cellular component organization or biogenesis | 2 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 12 |
GO:0003723 | RNA binding | 4 | 2 |
GO:0003729 | mRNA binding | 5 | 2 |
GO:0003743 | translation initiation factor activity | 4 | 12 |
GO:0005488 | binding | 1 | 12 |
GO:0005515 | protein binding | 2 | 2 |
GO:0008135 | translation factor activity, RNA binding | 3 | 12 |
GO:0031369 | translation initiation factor binding | 3 | 2 |
GO:0045182 | translation regulator activity | 1 | 12 |
GO:0090079 | translation regulator activity, nucleic acid binding | 2 | 12 |
GO:0097159 | organic cyclic compound binding | 2 | 12 |
GO:1901363 | heterocyclic compound binding | 2 | 12 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 78 | 82 | PF00656 | 0.811 |
CLV_NRD_NRD_1 | 10 | 12 | PF00675 | 0.691 |
CLV_NRD_NRD_1 | 271 | 273 | PF00675 | 0.451 |
CLV_NRD_NRD_1 | 306 | 308 | PF00675 | 0.327 |
CLV_PCSK_FUR_1 | 7 | 11 | PF00082 | 0.698 |
CLV_PCSK_KEX2_1 | 306 | 308 | PF00082 | 0.327 |
CLV_PCSK_KEX2_1 | 335 | 337 | PF00082 | 0.518 |
CLV_PCSK_KEX2_1 | 9 | 11 | PF00082 | 0.670 |
CLV_PCSK_PC1ET2_1 | 335 | 337 | PF00082 | 0.499 |
CLV_PCSK_SKI1_1 | 319 | 323 | PF00082 | 0.490 |
DEG_SPOP_SBC_1 | 161 | 165 | PF00917 | 0.562 |
DOC_MAPK_gen_1 | 335 | 345 | PF00069 | 0.531 |
DOC_MAPK_MEF2A_6 | 210 | 217 | PF00069 | 0.473 |
DOC_PP2B_LxvP_1 | 213 | 216 | PF13499 | 0.401 |
DOC_PP4_FxxP_1 | 238 | 241 | PF00568 | 0.322 |
DOC_USP7_MATH_1 | 162 | 166 | PF00917 | 0.641 |
DOC_USP7_MATH_1 | 172 | 176 | PF00917 | 0.690 |
DOC_USP7_MATH_1 | 51 | 55 | PF00917 | 0.749 |
LIG_14-3-3_CanoR_1 | 186 | 191 | PF00244 | 0.505 |
LIG_14-3-3_CanoR_1 | 272 | 281 | PF00244 | 0.451 |
LIG_APCC_ABBA_1 | 58 | 63 | PF00400 | 0.712 |
LIG_EVH1_2 | 99 | 103 | PF00568 | 0.504 |
LIG_FHA_1 | 26 | 32 | PF00498 | 0.807 |
LIG_FHA_1 | 316 | 322 | PF00498 | 0.413 |
LIG_FHA_2 | 166 | 172 | PF00498 | 0.704 |
LIG_FHA_2 | 273 | 279 | PF00498 | 0.322 |
LIG_FHA_2 | 28 | 34 | PF00498 | 0.857 |
LIG_LIR_Apic_2 | 236 | 241 | PF02991 | 0.401 |
LIG_LIR_Gen_1 | 111 | 120 | PF02991 | 0.532 |
LIG_LIR_Gen_1 | 156 | 162 | PF02991 | 0.628 |
LIG_LIR_Gen_1 | 275 | 285 | PF02991 | 0.350 |
LIG_LIR_Nem_3 | 111 | 115 | PF02991 | 0.534 |
LIG_LIR_Nem_3 | 116 | 120 | PF02991 | 0.473 |
LIG_LIR_Nem_3 | 156 | 161 | PF02991 | 0.595 |
LIG_LIR_Nem_3 | 192 | 198 | PF02991 | 0.543 |
LIG_LIR_Nem_3 | 275 | 280 | PF02991 | 0.329 |
LIG_MYND_3 | 215 | 219 | PF01753 | 0.451 |
LIG_PCNA_yPIPBox_3 | 186 | 195 | PF02747 | 0.580 |
LIG_SH2_CRK | 112 | 116 | PF00017 | 0.592 |
LIG_SH2_CRK | 117 | 121 | PF00017 | 0.508 |
LIG_SH2_STAP1 | 117 | 121 | PF00017 | 0.555 |
LIG_SH2_STAT5 | 284 | 287 | PF00017 | 0.307 |
LIG_SH2_STAT5 | 288 | 291 | PF00017 | 0.308 |
LIG_SH3_3 | 50 | 56 | PF00018 | 0.717 |
LIG_SH3_3 | 66 | 72 | PF00018 | 0.691 |
LIG_TRAF2_1 | 176 | 179 | PF00917 | 0.616 |
LIG_TRAF2_1 | 30 | 33 | PF00917 | 0.731 |
LIG_TYR_ITIM | 110 | 115 | PF00017 | 0.577 |
LIG_UBA3_1 | 217 | 225 | PF00899 | 0.451 |
LIG_UBA3_1 | 281 | 290 | PF00899 | 0.342 |
MOD_CK1_1 | 15 | 21 | PF00069 | 0.853 |
MOD_CK1_1 | 165 | 171 | PF00069 | 0.653 |
MOD_CK1_1 | 205 | 211 | PF00069 | 0.317 |
MOD_CK1_1 | 54 | 60 | PF00069 | 0.792 |
MOD_CK1_1 | 73 | 79 | PF00069 | 0.707 |
MOD_CK2_1 | 15 | 21 | PF00069 | 0.738 |
MOD_CK2_1 | 165 | 171 | PF00069 | 0.685 |
MOD_CK2_1 | 172 | 178 | PF00069 | 0.679 |
MOD_CK2_1 | 27 | 33 | PF00069 | 0.726 |
MOD_Cter_Amidation | 221 | 224 | PF01082 | 0.342 |
MOD_Cter_Amidation | 304 | 307 | PF01082 | 0.322 |
MOD_GlcNHglycan | 165 | 168 | PF01048 | 0.618 |
MOD_GlcNHglycan | 175 | 178 | PF01048 | 0.580 |
MOD_GlcNHglycan | 203 | 207 | PF01048 | 0.538 |
MOD_GlcNHglycan | 329 | 332 | PF01048 | 0.551 |
MOD_GlcNHglycan | 53 | 56 | PF01048 | 0.803 |
MOD_GlcNHglycan | 72 | 75 | PF01048 | 0.706 |
MOD_GlcNHglycan | 92 | 95 | PF01048 | 0.789 |
MOD_GSK3_1 | 12 | 19 | PF00069 | 0.838 |
MOD_GSK3_1 | 161 | 168 | PF00069 | 0.577 |
MOD_GSK3_1 | 27 | 34 | PF00069 | 0.557 |
MOD_GSK3_1 | 313 | 320 | PF00069 | 0.309 |
MOD_GSK3_1 | 323 | 330 | PF00069 | 0.520 |
MOD_GSK3_1 | 79 | 86 | PF00069 | 0.745 |
MOD_N-GLC_1 | 172 | 177 | PF02516 | 0.663 |
MOD_N-GLC_2 | 292 | 294 | PF02516 | 0.322 |
MOD_N-GLC_2 | 313 | 315 | PF02516 | 0.307 |
MOD_NEK2_2 | 56 | 61 | PF00069 | 0.640 |
MOD_PIKK_1 | 64 | 70 | PF00454 | 0.742 |
MOD_PK_1 | 251 | 257 | PF00069 | 0.322 |
MOD_PKA_1 | 223 | 229 | PF00069 | 0.451 |
MOD_PKA_1 | 272 | 278 | PF00069 | 0.451 |
MOD_PKA_2 | 125 | 131 | PF00069 | 0.541 |
MOD_Plk_1 | 143 | 149 | PF00069 | 0.617 |
MOD_Plk_1 | 251 | 257 | PF00069 | 0.326 |
MOD_Plk_1 | 297 | 303 | PF00069 | 0.307 |
MOD_Plk_2-3 | 17 | 23 | PF00069 | 0.747 |
MOD_Plk_4 | 186 | 192 | PF00069 | 0.471 |
MOD_Plk_4 | 223 | 229 | PF00069 | 0.451 |
MOD_SUMO_for_1 | 267 | 270 | PF00179 | 0.322 |
MOD_SUMO_rev_2 | 243 | 248 | PF00179 | 0.451 |
TRG_ENDOCYTIC_2 | 112 | 115 | PF00928 | 0.557 |
TRG_ENDOCYTIC_2 | 117 | 120 | PF00928 | 0.494 |
TRG_ENDOCYTIC_2 | 187 | 190 | PF00928 | 0.432 |
TRG_ER_diArg_1 | 306 | 308 | PF00400 | 0.325 |
TRG_ER_diArg_1 | 7 | 10 | PF00400 | 0.693 |
TRG_NLS_MonoExtN_4 | 220 | 227 | PF00514 | 0.322 |
TRG_Pf-PMV_PEXEL_1 | 283 | 287 | PF00026 | 0.322 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I3Y9 | Leptomonas seymouri | 72% | 99% |
A0A0S4KLD6 | Bodo saltans | 39% | 100% |
A0A1X0NPQ0 | Trypanosomatidae | 50% | 91% |
A0A3R7JYX9 | Trypanosoma rangeli | 51% | 100% |
A0A3S5H658 | Leishmania donovani | 98% | 100% |
A4H5C4 | Leishmania braziliensis | 87% | 100% |
A4HTK4 | Leishmania infantum | 97% | 100% |
C9ZPG8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 60% | 100% |
E9AMD5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 95% | 100% |
V5BGW0 | Trypanosoma cruzi | 52% | 100% |